Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB)

NCT00644449 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00644449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00644449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB)
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
March 31, 2004
Enrollment
551 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

bronchitis, chronic